InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2026-06-12 17:30:16 ET · period of report 2026-06-10 · accession 0001323212-26-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2026-06-12 17:30 2026-06-10 PTCT Pauwels Eric Chief BUSINESS Off S - Sale+OE $75.00 -21.3K 73.4K -22% -$1.60M
DT 2026-06-12 17:30 2026-06-10 PTCT Pauwels Eric Chief BUSINESS Off M - OptEx $18.01 +17.6K 91.0K +24% +$316.4K
DT 2026-06-12 17:30 2026-06-10 PTCT Pauwels Eric Chief BUSINESS Off S - Sale $0.00 -17.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-10 S D 3,711 $75.00 73,411 D — — (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026.
2 Common Common Stock 2026-06-10 M A 17,566 $18.01 90,977 D — — (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026.
3 Common Common Stock 2026-06-10 S D 17,566 $75.00 73,411 D — — (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026.
4 Derivative Stock Option (Right to Buy) 2026-06-10 S D 17,566 $0.00 0 D $18.01 · — to 2028-01-02 17,566 Common Stock (F1) This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on February 25, 2026. (F2) Currently exercisable.